Cargando…

T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual

Immunocompromised individuals are at higher risk of developing protracted and severe COVID-19, and understanding individual disease courses and SARS-CoV-2 immune responses in these individuals is of the utmost importance. For more than two years, we followed an immunocompromised individual with a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunse, Till, Koerber, Nina, Wintersteller, Hannah, Schneider, Jochen, Graf, Alexander, Radonic, Aleksandar, Thuermer, Andrea, von Kleist, Max, Blum, Helmut, Spinner, Christoph D., Bauer, Tanja, Knolle, Percy A., Protzer, Ulrike, Schulte, Eva C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304262/
https://www.ncbi.nlm.nih.gov/pubmed/37375064
http://dx.doi.org/10.3390/microorganisms11061562
_version_ 1785065465552306176
author Bunse, Till
Koerber, Nina
Wintersteller, Hannah
Schneider, Jochen
Graf, Alexander
Radonic, Aleksandar
Thuermer, Andrea
von Kleist, Max
Blum, Helmut
Spinner, Christoph D.
Bauer, Tanja
Knolle, Percy A.
Protzer, Ulrike
Schulte, Eva C.
author_facet Bunse, Till
Koerber, Nina
Wintersteller, Hannah
Schneider, Jochen
Graf, Alexander
Radonic, Aleksandar
Thuermer, Andrea
von Kleist, Max
Blum, Helmut
Spinner, Christoph D.
Bauer, Tanja
Knolle, Percy A.
Protzer, Ulrike
Schulte, Eva C.
author_sort Bunse, Till
collection PubMed
description Immunocompromised individuals are at higher risk of developing protracted and severe COVID-19, and understanding individual disease courses and SARS-CoV-2 immune responses in these individuals is of the utmost importance. For more than two years, we followed an immunocompromised individual with a protracted SARS-CoV-2 infection that was eventually cleared in the absence of a humoral neutralizing SARS-CoV-2 antibody response. By conducting an in-depth examination of this individual’s immune response and comparing it to a large cohort of convalescents who spontaneously cleared a SARS-CoV-2 infection, we shed light on the interplay between B- and T-cell immunity and how they interact in clearing SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-10304262
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103042622023-06-29 T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual Bunse, Till Koerber, Nina Wintersteller, Hannah Schneider, Jochen Graf, Alexander Radonic, Aleksandar Thuermer, Andrea von Kleist, Max Blum, Helmut Spinner, Christoph D. Bauer, Tanja Knolle, Percy A. Protzer, Ulrike Schulte, Eva C. Microorganisms Case Report Immunocompromised individuals are at higher risk of developing protracted and severe COVID-19, and understanding individual disease courses and SARS-CoV-2 immune responses in these individuals is of the utmost importance. For more than two years, we followed an immunocompromised individual with a protracted SARS-CoV-2 infection that was eventually cleared in the absence of a humoral neutralizing SARS-CoV-2 antibody response. By conducting an in-depth examination of this individual’s immune response and comparing it to a large cohort of convalescents who spontaneously cleared a SARS-CoV-2 infection, we shed light on the interplay between B- and T-cell immunity and how they interact in clearing SARS-CoV-2 infection. MDPI 2023-06-12 /pmc/articles/PMC10304262/ /pubmed/37375064 http://dx.doi.org/10.3390/microorganisms11061562 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Bunse, Till
Koerber, Nina
Wintersteller, Hannah
Schneider, Jochen
Graf, Alexander
Radonic, Aleksandar
Thuermer, Andrea
von Kleist, Max
Blum, Helmut
Spinner, Christoph D.
Bauer, Tanja
Knolle, Percy A.
Protzer, Ulrike
Schulte, Eva C.
T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
title T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
title_full T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
title_fullStr T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
title_full_unstemmed T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
title_short T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
title_sort t-cell-dominated immune response resolves protracted sars-cov-2 infection in the absence of neutralizing antibodies in an immunocompromised individual
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304262/
https://www.ncbi.nlm.nih.gov/pubmed/37375064
http://dx.doi.org/10.3390/microorganisms11061562
work_keys_str_mv AT bunsetill tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT koerbernina tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT winterstellerhannah tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT schneiderjochen tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT grafalexander tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT radonicaleksandar tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT thuermerandrea tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT vonkleistmax tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT blumhelmut tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT spinnerchristophd tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT bauertanja tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT knollepercya tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT protzerulrike tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual
AT schulteevac tcelldominatedimmuneresponseresolvesprotractedsarscov2infectionintheabsenceofneutralizingantibodiesinanimmunocompromisedindividual